Our Attendees Include:

• Adult and pediatric hepatology experts.
• Clinical, basic, and translational researchers.
• Specialists who diagnose and treat liver disease, including gastroenterologists, surgeons, clinical pathologists, anesthesiologists, and radiologists.
• Primary care physicians.
• Nurse practitioners, registered nurses, physician assistants, pharmacists, and other allied health professionals in hepatology and the disciplines listed above.
• Trainees, and students in the disciplines listed above.
• Patient advocates and patients.

Topics : 

- 2021 Academic Debates
- AASLD & AASLD Foundation Awards & Honors Ceremony
- AASLD Distinguished Award
- AASLD_ALEH Joint Symposium
- AASLD_ASGE Endoscopy Course Live Q&A Session
- AASLD_ILTS Transplant Course Live Q&A Session
- Alcohol, Cancer, Fibrosis Cirrhosis Portal Hypertension
- Alcohol, NASH and NAFLD
- Alcohol-associated Liver Disease
- Associates, Health Outcomes, Fibrosis Cirrhosis Portal Hypertension, TransplantLiver Failure
- Basic Translational Science, Microbiome Genomics Personalized Medicine
- Basic Science Debrief
- Cancer, Transplant Liver Failure, NASH and NAFLD
- Career Development Workshop
- Cholestatic and Autoimmune Liver Diseases
- Cirrhosis Improving Quality through Patient Empowerment
- Clinical Hepatology Debrief
- Clinical Research Workshop - Part I
- Clinical Research Workshop - Part II
- COVID-19 and the Liver Symposium
- Diversity Workshop
- Emerging Trends Symposium
- Fibrosis Cirrhosis Portal Hypertension, TransplantLiver Failure, Pediatric
- Grit, Grace, Gratitude, and Resilience What You Wish Your Doctors Knew About You
- HBV Cure How Close Are We
- HBV Global Symposium
- Health Outcomes, Fibrosis Cirrhosis Portal Hypertension, TransplantLiver Failure, NASH and NAFLD
- Health Outcomes, Public Health
- Health Outcomes, Training and Career Development, Public Health
- Hepatitis B
- Hepatitis C
- Hepatitis Debrief
- Hepatology Associates
- Hepatotoxicity SIG
- Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture
- Leon Schiff State-of-the-Art Lecture
- Liver Cancer
- Liver Cell Biology
- Liver Fibrosis
- Liver Transplantation and Surgery SIG
- Making an Impact Where You Are Patient Voices as a Vehicle for Change
- Microbiome Genomics Personalized Medicine
- NAFLD Debrief
- Nonalcoholic Fatty Liver Disease
- Nutrition 101 for Patients with Chronic Liver Disease
- Panel Discussion Saving More Lives Forward from “A Burden of Genius”
- Parallel 1 Advances with Approved HBV Therapies
- Parallel 2 Health Services and Public Health
- Parallel 3 Metabolic and Genetic Disease Hemochromatosis, Wilsons Disease, Alpha-1 Antitrypsin Deficiency
- Parallel 4 COVID-19 Clinical
- Parallel 5 Pediatric Hepatology Metabolic and Genetic Diseases
- Parallel 6- Experimental and Translational Portal Hypertension and ACLF - The World’s Premier Event in Hepatology
- Parallel 7 Immunosuppression, Outcomes, Complications
- Parallel 8 HBV Cascade of Care, Natural History and Diagnostics
- Parallel 9 COVID-19 Translational and Clinical
- Parallel 10 Diagnostics and Biomarkers of NAFLD
- Parallel 11 Healthcare Quality and Access in Hepatology
- Parallel 12 Donor and Allocation Issues, Living and Split Donor Liver Transplantation
- Parallel 13 Novel HBV Therapies and Approaches
- Parallel 14 Hepatitis C Oral Session
- Parallel 15 Biomarkers and Therapeutics in Autoimmune and Cholestatic Diseases
- Parallel 16 Experimental and Translational Advances in Alcohol-Associated Liver Disease
- Parallel 17 NAFLD and NASH Predicting Outcomes and Response to Interventions
- Parallel 18 Mechanisms of Cholestatic Liver Injury
- Parallel 19 Clinical Advances in Alcohol-Associated Liver Disease
- Parallel 20 Hepatobiliary Neoplasia Clinical Oral Session
- Parallel 21 NAFLD and NASH Clinical Trials of Novel Therapeutics
- Parallel 22 Portal Hypertension Risk Stratification and Treatment for Varices
- Parallel 23 Cell and Molecular Biology
- Parallel 24 Hepatobiliary Neoplasia Experimental Translational Oral Session
- Parallel 25 Portal Hypertension Clinical
- Parallel 26 Liver Fibrogenesis and Non-Parenchymal Cell Biology
- Parallel 27 Diversity, Equity, and Inclusion in Liver Disease Care
- Parallel 28 Gut Liver Axis and Microbiome
- Parallel 29 NAFLD and NASH Management and Outcomes in the Clinic
- Parallel 30- Genomics and Precision Medicine - The World’s Premier Event in Hepatology
- Parallel 31 Clinical Translational Research in Pediatric Hepatology
- Parallel 32 Clinical Acute on Chronic Liver Failure
- Parallel 34 Basic Science Research in Pediatric Hepatology
- Parallel 35 Viral Hepatitis Oral Session (Non-HBV, Non-HCV)
- Parallel 36 Hepatotoxicity
- Patient Annual Forum and Meet & Greet Networking
- Patient Debrief
- Patient Keynote How Physician-Patient Partnerships Can Improve Liver Disease Care & Research
- Pediatric Liver Disorders and Acute on Chronic Liver Failure SIG Program - Part I Management of Acute-on-Chronic Liver Failure in Adults and Children
- Pediatric Liver Disorders and Acute on Chronic Liver Failure SIG Program - Part II Management of Acute-on-Chronic Liver Failure in Adults and Children
- Pediatric, Cholestatic and Autoimmune Liver Disease
- Portal Hypertension Clinical and Experimental
- Postgraduate Course - Part I
- Postgraduate Course - Part II
- Postgraduate Course - Part III
- Postgraduate Course Live Q&A Session
- Practice Guidelines Debrief for Patients
- Practice Guidelines Workshop
- Presidential Plenary Basic and Translational
- Presidential Plenary Clinical and Translational
- Presidential Plenary Liver Transplant
- Presidential Welcome and President's Choice Lecture
- Public Health Health Care Delivery
- The Liver Meeting Closing Remarks
- Transplant Surgery Workshop Part I (Increased-risk Organs)
- Transplant Surgery Workshop Part II (Living Donor, Split Liver)
- TransplantLiver Failure, Microbiome Genomics Personalized Medicine
- Viral Hepatitis Elimination Session
- Women’s Health Program

Release Date : November 13-16 2021